Tuesday, June 21, 2016
- 12:30pm-2:00pm
-
A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome
Tics/Stereotypies · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
A pilot study of whole exome sequencing in progressive supranuclear palsy
Genetics (NON-PD) · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD)
Drug-induced movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
A rare genetic transcriptomopathy syndrome involving TAF1 leading to insights into more common neurologic disorders, including X-linked dystonia-parkinsonism (XDP)
Genetics (NON-PD) · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
A strategy to classify Parkinson’s disease patients with dyskinesia: The analysis of center of pressure with impact of cognitive loading
Technology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
A survey of movement disorders in a large sample of patients treated with antipsychotic medication
Drug-induced movement disorders · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
A validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson’s disease
Technology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
A web resource on levodopa-induced dyskinesia (LID) genetics
Parkinson's disease: Genetics · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
A whole brain anatomical network model and its application in PD research
Parkinson's disease: Pathophysiology · Exhibit Hall located in Hall B, Level 2
- 12:30pm-2:00pm
-
Age associated effects of levodopa administration on striatal acetylcholinesterase activity
Drug-induced movement disorders · Exhibit Hall located in Hall B, Level 2
- «Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 48
- Next Page»